Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances

被引:29
作者
Arjona-Sanchez, A. [1 ,2 ]
Cadenas-Febres, A. [1 ]
Cabrera-Bermon, J. [1 ]
Munoz-Casares, F. C. [1 ,2 ]
Casado-Adam, A. [1 ]
Sanchez-Hidalgo, J. M. [1 ,2 ]
Lopez-Andreu, M. [3 ]
Briceno-Delgado, J. [1 ,2 ]
Rufian-Pena, S. [1 ,2 ]
机构
[1] Univ Hosp Reina Sofia, Unit Oncol & Pancreat Surg, Av Menendez Pidal S-N, Cordoba 14004, Spain
[2] Univ Hosp Reina Sofia, CIBERehd, IMIBIC, Cordoba, Spain
[3] Univ Hosp Reina Sofia, Nephrol Unit, Cordoba, Spain
来源
EJSO | 2016年 / 42卷 / 06期
关键词
Acute renal failure; RIFLE; HIPEC; Peritoneal carcinomatosis; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; ACUTE KIDNEY INJURY; CYTOREDUCTIVE SURGERY; CARCINOMATOSIS; MORBIDITY; MORTALITY; OUTCOMES;
D O I
10.1016/j.ejso.2015.12.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The acute renal dysfunction (ARD) is a common complication in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Our aim is evaluate the ARD post-HIPEC procedures using the RIFLE and AKIN criteria. Evaluate the risk factors and analyze ARD's impact on postoperative course. Methods: From 2011 to 2014, in a retrospective way using a prospective database were operated by HIPEC procedure. The ARD was analyzed by RIFLE and AKIN criteria. The perioperative features were analyzed and a multivariate analysis was performed to define the risk factors to develop the ARD. Results: 141 patients were treated and analyzed. The ARD was detected in 30.5% (Injury 18.4% and Failure 12.1%) when RIFLE criteria were applied. The multivariate analysis detected that decrease of pH during HIPEC [OR = 29.39 (5.09-169.76)], PCI [OR = 1.07 (1.01-1.15)] and ureteral catheters [OR = 12.71 (1.44-111.85)] were associated to the development of acute renal injury (ARI) post-HIPEC. Decrease of Na during HIPEC [OR = 1.15 (1.01-1.30)], intraoperative inotrope use [OR = 3.83 (1.12-13.09)] and PCI [OR = 1.06 (1.0-1.14)] were associated to acute renal failure (ARF) post-HIPEC. The ARD was related to a higher length of stay hospital (17.2 +/- 11 vs. 13.8 +/- 8 days) (p = 0.05) but no impact in early survival was observed in ARD group. Conclusions: The widespread use of RIFLE criteria for ARD would have major benefits in terms of accurately diagnosing patients undergone HIPEC procedures. The ARD has a detrimental impact in length of stay hospital. The knowledge of risk factors helps us to prevent the ARD post-HIPEC by means of an aggressive and multidisciplinary perioperative management. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:869 / 876
页数:8
相关论文
共 25 条
[1]   Outcome of Patients with Aggressive Pseudomyxoma Peritonei Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy [J].
Arjona-Sanchez, Alvaro ;
Cristobal Munoz-Casares, Francisco ;
Casado-Adam, Angela ;
Manuel Sanchez-Hidalgo, Juan ;
Ayllon Teran, Maria Dolores ;
Orti-Rodriguez, Rafael ;
Cristina Padial-Aguado, Ana ;
Medina-Fernandez, Javier ;
Ortega-Salas, Rosa ;
Pulido-Cortijo, Gema ;
Gomez-Espana, Auxiliadora ;
Rufian-Pena, Sebastian .
WORLD JOURNAL OF SURGERY, 2013, 37 (06) :1263-1270
[2]   Morbidity and Mortality of Cytoreduction with Intraperitoneal Chemotherapy: Outcomes from the ACS NSQIP Database [J].
Bartlett, Edmund K. ;
Meise, Chelsey ;
Roses, Robert E. ;
Fraker, Douglas L. ;
Kelz, Rachel R. ;
Karakousis, Giorgos C. .
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (05) :1494-1500
[3]   Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group [J].
Bellomo, R ;
Ronco, C ;
Kellum, JA ;
Mehta, RL ;
Palevsky, P .
CRITICAL CARE, 2004, 8 (04) :R204-R212
[4]   Complications and Toxicities After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy [J].
Canda, Aras Emre ;
Sokmen, Selman ;
Terzi, Cem ;
Arslan, Cigdem ;
Oztop, Ilhan ;
Karabulut, Bulent ;
Ozzeybek, Deniz ;
Sarioglu, Sulen ;
Fuzun, Mehmet .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (04) :1082-1087
[5]   Effect of perfusion temperature on glucose and electrolyte transport during hyperthermic intraperitoneal chemoperfusion (HIPEC) with oxaliplatin [J].
Ceelen, W. ;
De Somer, F. ;
Van Nieuwenhove, Y. ;
Vande Putte, D. ;
Pattyn, P. .
EJSO, 2013, 39 (07) :754-759
[6]   Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure? A Systematic Review of Morbidity and Mortality [J].
Chua, Terence C. ;
Yan, Tristan D. ;
Saxena, Akshat ;
Morris, David L. .
ANNALS OF SURGERY, 2009, 249 (06) :900-907
[7]   Ureteral Stenting in Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy as a Routine Procedure: Evidence and Necessity [J].
Coccolini, Federico ;
Lotti, Marco ;
Manfredi, Roberto ;
Catena, Fausto ;
Vallicelli, Carlo ;
De Iaco, Pier Andrea ;
Da Pozzo, Luigi ;
Frigerio, Luigi ;
Ansaloni, Luca .
UROLOGIA INTERNATIONALIS, 2012, 89 (03) :307-310
[8]   Population Pharmacokinetics and Pharmacodynamics of Cisplatinum During Hyperthermic Intraperitoneal Chemotherapy Using a Closed Abdominal Procedure [J].
Cotte, Eddy ;
Colomban, Olivier ;
Guitton, Jerome ;
Tranchand, Brigitte ;
Bakrin, Nawel ;
Gilly, Francois-Noel ;
Glehen, Olivier ;
Tod, Michel .
JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (01) :9-18
[9]   The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery [J].
Hakeam, Hakeam A. ;
Breakiet, Mohammed ;
Azzam, Ayman ;
Nadeem, Ashraf ;
Amin, Tarek .
RENAL FAILURE, 2014, 36 (10) :1486-1491
[10]   RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis [J].
Hoste, Eric A. J. ;
Clermont, Gilles ;
Kersten, Alexander ;
Venkataraman, Ramesh ;
Angus, Derek C. ;
De Bacquer, Dirk ;
Kellum, John A. .
CRITICAL CARE, 2006, 10 (03)